Alex T Legocki1, Emily M Zepeda1, Thomas B Gillette1, Laura E Grant1, Ayesha Shariff1, Phanith Touch1, Aaron Y Lee1, Leona Ding1, Marcela M Estrada1, Kristina Tarczy-Hornoch2, Cecilia S Lee1, Dennis E Mayock3, Kathryn L Pepple1, Michelle T Cabrera4. 1. Department of Ophthalmology, University of Washington, Seattle, Washington. 2. Department of Ophthalmology, University of Washington, Seattle, Washington; Department of Ophthalmology, Seattle Children's Hospital, Seattle, Washington. 3. Department of Pediatrics, University of Washington, Seattle, Washington; Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington. 4. Department of Ophthalmology, University of Washington, Seattle, Washington; Department of Ophthalmology, Seattle Children's Hospital, Seattle, Washington. Electronic address: cabreram@uw.edu.
Abstract
PURPOSE: To evaluate the association between retinopathy of prematurity (ROP) and vitreous findings in premature infants detected by handheld spectral-domain (SD) OCT. DESIGN: Prospective, observational cohort study. PARTICIPANTS: Consecutive sample of 92 premature infants requiring ROP screening at 2 academic neonatal intensive care units between July 2015 and March 2018. METHODS: Infants underwent handheld SD OCT at the time of routine ROP examinations. Two masked, trained graders analyzed right-eye vitreoretinal findings, including semiautomated quantification of punctate hyperreflective vitreous opacities within 5 foveal or parafoveal B-scans (vitreous opacity ratio). MAIN OUTCOME MEASURES: Excluding posttreatment data, vitreous findings were compared with clinical ROP diagnoses. RESULTS: Agreement between image graders for all vitreoretinal findings was 91% (κ = 0.86; 95% confidence interval, 0.82-0.90; P < 0.001). Among 92 infants undergoing 280 imaging sessions (52% male; mean gestational age, 28.3 ± 2.8 weeks; mean birthweight, 1014.5 ± 285.0 g), 36 of 92 (39%) demonstrated ROP. Punctate hyperreflective vitreous opacities were identified in 61 of 92 infants (66%). The presence of punctate hyperreflective vitreous opacities at least once was associated with a diagnosis of ROP (62% vs. 29% without opacities; P = 0.003), maximum ROP stage (P = 0.001), preplus or plus disease (24% vs. 5%; P = 0.005), and type 1 disease (14% vs. 2%; P = 0.03). Among 29 infants (45 imaging sessions) with right-eye punctate hyperreflective vitreous opacities, the vitreous opacity ratio from 2 graders (F1 score, 0.82 ± 0.36; Dice coefficient, 0.97 ± 0.04) correlated with ROP stage (P = 0.02). Tractional vitreous bands on imaging correlated with plus disease status (29% vs. 5% without bands; P = 0.05). CONCLUSIONS: Punctate hyperreflective vitreous opacities and tractional vitreous bands predict the presence and severity of ROP. Further studies should explore handheld OCT as a noninvasive ROP screening tool.
PURPOSE: To evaluate the association between retinopathy of prematurity (ROP) and vitreous findings in premature infants detected by handheld spectral-domain (SD) OCT. DESIGN: Prospective, observational cohort study. PARTICIPANTS: Consecutive sample of 92 premature infants requiring ROP screening at 2 academic neonatal intensive care units between July 2015 and March 2018. METHODS: Infants underwent handheld SD OCT at the time of routine ROP examinations. Two masked, trained graders analyzed right-eye vitreoretinal findings, including semiautomated quantification of punctate hyperreflective vitreous opacities within 5 foveal or parafoveal B-scans (vitreous opacity ratio). MAIN OUTCOME MEASURES: Excluding posttreatment data, vitreous findings were compared with clinical ROP diagnoses. RESULTS: Agreement between image graders for all vitreoretinal findings was 91% (κ = 0.86; 95% confidence interval, 0.82-0.90; P < 0.001). Among 92 infants undergoing 280 imaging sessions (52% male; mean gestational age, 28.3 ± 2.8 weeks; mean birthweight, 1014.5 ± 285.0 g), 36 of 92 (39%) demonstrated ROP. Punctate hyperreflective vitreous opacities were identified in 61 of 92 infants (66%). The presence of punctate hyperreflective vitreous opacities at least once was associated with a diagnosis of ROP (62% vs. 29% without opacities; P = 0.003), maximum ROP stage (P = 0.001), preplus or plus disease (24% vs. 5%; P = 0.005), and type 1 disease (14% vs. 2%; P = 0.03). Among 29 infants (45 imaging sessions) with right-eye punctate hyperreflective vitreous opacities, the vitreous opacity ratio from 2 graders (F1 score, 0.82 ± 0.36; Dice coefficient, 0.97 ± 0.04) correlated with ROP stage (P = 0.02). Tractional vitreous bands on imaging correlated with plus disease status (29% vs. 5% without bands; P = 0.05). CONCLUSIONS: Punctate hyperreflective vitreous opacities and tractional vitreous bands predict the presence and severity of ROP. Further studies should explore handheld OCT as a noninvasive ROP screening tool.
Authors: Annie C Lee; Ramiro S Maldonado; Neeru Sarin; Rachelle V O'Connell; David K Wallace; Sharon F Freedman; Michael Cotten; Cynthia A Toth Journal: Retina Date: 2011-09 Impact factor: 4.256
Authors: Ramiro S Maldonado; Eric Yuan; Du Tran-Viet; Adam L Rothman; Amy Y Tong; David K Wallace; Sharon F Freedman; Cynthia A Toth Journal: Ophthalmology Date: 2014-01-21 Impact factor: 12.079
Authors: Ramiro S Maldonado; Joseph A Izatt; Neeru Sarin; David K Wallace; Sharon Freedman; C Michael Cotten; Cynthia A Toth Journal: Invest Ophthalmol Vis Sci Date: 2010-01-13 Impact factor: 4.799
Authors: M Teresa Moral-Pumarega; Sonia Caserío-Carbonero; Javier De-La-Cruz-Bértolo; Pilar Tejada-Palacios; David Lora-Pablos; Carmen R Pallás-Alonso Journal: BMC Pediatr Date: 2012-08-28 Impact factor: 2.125
Authors: Thanh-Tin P Nguyen; Shuibin Ni; Guangru Liang; Shanjida Khan; Xiang Wei; Alison Skalet; Susan Ostmo; Michael F Chiang; Yali Jia; David Huang; Yifan Jian; J Peter Campbell Journal: Front Med (Lausanne) Date: 2022-07-04
Authors: Laura C Huang; Hao Zhou; Alex T Legocki; N Max Scoville; Junping Zhong; Leona Ding; Ruikang K Wang; Michelle T Cabrera Journal: Transl Vis Sci Technol Date: 2021-02-05 Impact factor: 3.283
Authors: Brittni A Scruggs; Shuibin Ni; Thanh-Tin P Nguyen; Susan Ostmo; Michael F Chiang; Yali Jia; David Huang; Yifan Jian; J Peter Campbell Journal: Ophthalmol Sci Date: 2022-01-11
Authors: Alex T Legocki; Yasman Moshiri; Emily M Zepeda; Thomas B Gillette; Ayesha Shariff; Laura E Grant; Leona Ding; Aaron Y Lee; Cecilia S Lee; Kristina Tarczy-Hornoch; Michelle T Cabrera Journal: J AAPOS Date: 2021-05-24 Impact factor: 1.325
Authors: Thanh-Tin P Nguyen; Shuibin Ni; Shanjida Khan; Xiang Wei; Susan Ostmo; Michael F Chiang; Yali Jia; David Huang; Yifan Jian; J Peter Campbell Journal: Front Pediatr Date: 2022-01-18 Impact factor: 3.418